AMGN vs OMER · P/E 24, rev $10.05B vs rev $38.4M
Amgen Inc (AMGN) versus Omeros Corporation (OMER) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Omeros Corporation (OMER) is a biotechnology company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported OMER revenue for 2026-06-30 was $38.4M. Net income was $69.3M. OMER currently screens at market cap $174.0M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. OMER currently screens at market cap $174.0M.
Not investment advice. Open the AMGN and OMER stock pages for the full models.
Not investment advice.